Stock Price
12.50
Daily Change
-0.08 -0.64%
Monthly
23.58%
Yearly
-70.41%
Q3 Forecast
12.48

Tandem Diabetes Care reported $-52400000 in Net Income for its fiscal quarter ending in June of 2025.



Financials
Assets USD 875.74M
Cost of Sales USD 114.82M
Current Assets USD 614.82M
Debt USD 449.01M
EBIT USD -31.86M
EBITDA USD -1.85M
Employees 2.65K
Interest Income USD 4.19M
Loan Capital USD 309.15M
Net Income USD -52.4M
Operating Expenses USD 272.54M
Operating Profit USD -31.86M
Pre-Tax Profit USD -57.72M
Sales Revenues USD 240.68M
Stock USD 142.57M
Trade Creditors USD 55.84M
Trade Debtors USD 128.44M

Net Income Change Date
Abbott USD 1.78B 454M Jun/2025
Align Technology USD 124.61M 31.38M Jun/2025
AtriCure USD -6190000 557K Jun/2025
Baxter International USD 91M 35M Jun/2025
Becton, Dickinson and Co. USD 574M 266M Jun/2025
Boston Scientific USD 797M 123M Jun/2025
Cooper Companies USD 98.3M 10.6M Jul/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 333.2M 24.8M Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Globus Medical USD 202.85M 127.38M Jun/2025
ICU Medical USD 35.34M 50.81M Jun/2025
Insulet USD 22.5M 12.9M Jun/2025
Integra LifeSciences USD -484073000 458.78M Jun/2025
Intuitive Surgical USD 658.4M 40M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Masimo USD 51.3M 222M Jun/2025
Medtronic USD 1.04B 17M Jul/2025
Merit Medical Systems USD 32.58M 2.43M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Stryker USD 884M 230M Jun/2025
Tandem Diabetes Care USD -52400000 78.16M Jun/2025
Teleflex USD 122.58M 27.58M Jun/2025
Zimmer Biomet Holdings USD 152.8M 29.2M Jun/2025